US OptionsDetailed Quotes
MLSS241220P7500
- 0.00
- 0.000.00%
15min DelayClose Dec 2 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-702.14%PremiumDec 20, 2024Expiry Date6.56Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.14Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Milestone Scientific Stock Discussion
I know nothing about this company I'm just putting out there maybe somebody here owns it or wants to learn more about it good luck to you it's being pumped up now on CNBC with commercials
Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care
Milestone Scientific (NYSE: MLSS) announced the commercial rollout of its CompuFlo® Epidural System at Hudson Specialty Care, led by Dr. Elbaz. This expansion follows the recent Medicare Part B payment rate assignment with FCSO and Novitas Solutions under CPT code CPT0777T. The implementation results from M...
Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida
Milestone Scientific Inc. (NYSE: MLSS) has announced a strategic partnership with Axial Biologics to distribute its CompuFlo® Epidural System in New Jersey, Texas, and Florida. This follows recent Medicare Part B Physician payment rate approvals for the system under the AMA's Category III CPT® code CPT0777T by Novitas Solutions, I...
Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe
Milestone Scientific Inc. (NYSE: MLSS) has received multiple Notices of Allowance for key patent applications in the U.S. and Europe.
These patents cover the company's next-generation Dynamic Pressure Sensing® (DPS) technology for real-time pressure-sensing guidance in manual injection systems and the new CompuPulse System for identifying pulsatile pressure waveforms.
The DPS technology...
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
Milestone Scientific has received approval from Brazil's National Health Surveillance Agency (ANVISA) to market its CompuFlo® Epidural System in Brazil. This system uses patented Dynamic Pressure Sensing® technology for accurate, safe, and comfortable epidural needle placement, applicable to lumbar, thoracic, and cervical-thoracic areas. Brazil, being the 9th larges...
time to load up for the pop!
$Boqii (BQ.US)$ to be the bext $Alibaba (BABA.US)$ $20+ minimum in 3 months
$Milestone Scientific (MLSS.US)$ $2 + minimum by OCT
No comment yet